Drilldown: Medicines

Nav

Choose a table:

Medicines (732)

Medicines > mechanism: None

& routes

: IV

or Subcutaneous

Use the filters below to narrow your results.

Other values:

Other values:

'"`UNIQ--vote-0000001B-QINU`"', '"`UNIQ--vote-0000001C-QINU`"', '"`UNIQ--vote-0000001D-QINU`"', '"`UNIQ--vote-0000001E-QINU`"', '"`UNIQ--vote-0000001F-QINU`"' (2)

Other values:

40 mg/d (2) · Indication-specific (2)

Other values:

1-2 hours (1) · 10 minutes (SC); 15-30 minutes (nasal); 30-60 minutes (oral) (1) · 15-60 minutes (oral); 1-5 minutes (IV); 4-10 minutes (rectal or intranasal) (1) · 30 minutes (IM); 30-60 minutes (oral) (1) · 30 minutes PO; minutes IV (1) · 5-10 minutes (IV); 30 minutes (oral IR); slower for ER and rectal (1) · BP effect 1 hour; max at 4-6 hours (1) · Clinical improvement within 24-72 hours (2) · Days for calcium effect; weeks for PTH suppression (1) · Days for immunosuppressive effect (1) · Days for symptom improvement in scurvy (1) · Hematologic response within days (1) · Hours (9) · Hours (faster than T4); peak biologic activity 24-48 hours (1) · Hours (PO); IV faster but rate-limited (1) · Hours (systemic); minutes (ophthalmic) (1) · IV/IM 1-3 minutes; PO 30-60 minutes (1) · IV: 1-3 minutes (SVT termination); PO IR: 30-60 minutes; ER: hours (1) · IV: 5 minutes; PO: 30-60 minutes (1) · IV: 5-20 minutes; PO: 30-60 minutes (1) · IV: minutes; oral: weeks to load (1) · LDL reduction ~50-60% from baseline at 1-2 weeks (1) · Oral analgesic effect 30-60 minutes; opioid-withdrawal suppression 30 minutes (oral); IV ~10 minutes (1) · PO 30-60 minutes; IV minutes (1) · PO: 30-60 minutes; IV: minutes (1) · Reticulocyte response at 3-5 days; neurologic recovery weeks to months (and may be incomplete if longstanding) (1) · Rheumatologic effect at 4-8 weeks; ectopic resolution over 2-3 weeks (1) · SC: 5-15 minutes (Fiasp 2.5 minutes earlier on average) (1) · Serum urate falls gradually over days to weeks; acute flare prevention requires colchicine cover during initiation (1) · SL/spray: 1-3 minutes; IV: minutes; patch: 30-60 minutes (1) · Smoked 2-5 min; insufflated 5-15 min; oral 30-60 min; IV / IM ~5-15 min (1) · Symptom relief within 24-48 hours of starting episodic treatment (1) · Topical: inflammation, erythema, crusting at 2 weeks; complete response weeks to months after course (1)

12 hours (1) · 12-24 hours (1) · 2-4 hours; headache recurrence rate ~20-30% within 24 hours (1) · 2-4 weeks per dose (1) · 24 hours (3) · 24-72 hours (1) · 3-5 hours (1) · 3-5 hours (IR); 8-24 hours (ER); 12-24 hours (epidural / intrathecal) (1) · 4-12 hours (1) · 4-6 hours (4) · 4-8 hours typical; longer at high doses; residual cognitive and perceptual effects up to 48 hours (1) · 6-12 hours systemic (1) · 6-24 hours (parent); much longer when accounting for the long-lived active metabolites (1) · 6-8 hours (2) · 8 hours per oral dose (1) · 8-12 hours (3) · Analgesic effect 4-8 hours (much shorter than half-life would suggest, due to receptor kinetics); MOUD effect (opioid withdrawal suppression) 24-36 hours per single daily dose (1) · Biologic 36-72 hours (long-acting) (1) · Biologic ~8-12 hours (short-acting) (1) · Dosing-frequency dependent (1) · Hours (1) · Hours per dose (much shorter biologic effect than ergocalciferol/cholecalciferol because it is the already-active form, not the storage form) (1) · IR: 6-8 hours; ER: 24 hours (1) · IV: 1-4 hours; PO: 3-8 hours (1) · IV: ~2 hours; PO: 6-8 hours (1) · N/A (1) · N/A (replacement) (2) · Once-weekly dosing in rheumatology (1) · SL: 30 minutes; patch: 12-14 hours; IV continuous (1) · Tissue half-life supports once-daily and post-treatment effect (1) · Variable; depends on ongoing losses (1) · Weeks after discontinuation (extremely long half-life) (1) · ~12-24 hours (dose-dependent; BID dosing often needed at higher doses) (1)

Other values:

A

B

C

D

E

F

H

I

K

L

M

N

O

P

S

T

V